English中文

Treatment Selection

Click For More

Recurrence Detection

Click For More

Early Detection

Click For More

About Cellomics


Cellomics is a leading Great Bay Area based biotech company focusing on the development and commercialization of liquid biopsy products and services for early screening and disease management of cancer.

Treatment

Selection

Recurrence

Detection

Early

Detection

Liquid Biopsy


Liquid Biopsy is a non-invasive technology to facilitate cancer detection. The applications include screening cancer at early stage, cancer reoccurrence detection, and monitoring treatment effect…

Find out more



  Please click on the right side of the picture  


Liquid Biopsy


Liquid Biopsy is a non-invasive technology to facilitate cancer detection. The applications include screening cancer at early stage, cancer reoccurrence detection, and monitoring treatment effect…



Find out more



  Please click on the right side of the picture  


Cancer Statistics


GLOBOCAN (Global Cancer Incidence, Mortality and Prevalence ) estimates of incidence and mortality worldwide for 36 cancers in 185 countries.Cancer Early Detection and Diagnosis is essential.

18078957 +

New Cases

9555027 +

Cancer Mortality

8751000 +

New Cases in Asia

5477064 +

Asia Cancer Death

18078957 +

New Cases

9555027 +

Cancer Mortality

8751000 +

New Cases in Asia

5477064 +

Asia Cancer Death

Scientific Application


Cellomics excels in microfluidics, which is a system that manipulate and control a small quantities of fluid in microscale channels. Our patented microfluidic chip allows us to enrich viable CTCs from blood samples with the help of CTC physical and biological properties in high speed, high accuracy and high sensitivity.


 

 

Efficiency

 

 Takes only 5 minutes 

 to process 10ml of sample 



Accuracy


 Detecting limit can be 

 as low as 1 CTC per 1 ml blood sample 




Extensiveness


 Broad applications 

 in CTC downstream analysis 

Scientific Application


Cellomics excels in microfluidics, which is a system that manipulate and control a small quantities of fluid in microscale channels. Our patented microfluidic chip allows us to enrich viable CTCs from blood samples with the help of CTC physical and biological properties in high speed, high accuracy and high sensitivity.


Efficiency

Takes only 5 minutes to process 10ml of sample

Accuracy

Detecting limit can be as low as 1 CTC per 1 ml blood sample

Comprehensive

Broad applications in CTC downstream analysis

图片展示
图片展示
图片展示
图片展示
图片展示
图片展示
图片展示
图片展示
图片展示

About


Company Profile

Enterprise Culture

Organizational Structure

Research Leader

Team Elegant Demeanour

Honor & Qualification

Investment & Cooperation

Laboratory

Solution

 

 

 

 

 

Product





News


Patient Story 

Research Results

Enterprise Dynamic

Latest Information


 WeChat Public Number



Copyright @ Cellomics All Rights Reserved  Email:info@cellomicsbio.com  Tel:+86-0755-28378001